Insider trades

Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.

Open-market buys
1,007 trades
$2.1B in total
Open-market sales
1,285 trades
$2.7B in total
Insiders filing
580 insiders
Last 7 days
Trade type
RXORXO
Open-market buy02/1202/17532,276 sh$12.00$6,387,312+1.9%
RXORXO
Open-market buy02/1202/17532,276 sh$12.00$6,387,312+1.9%
RXORXO
Open-market buy02/1202/17532,276 sh$12.00$6,387,312+1.9%
RXORXO
Open-market buy02/1202/17532,276 sh$12.00$6,387,312+1.9%
RXORXO
Open-market buy02/1202/17532,276 sh$12.00$6,387,312+1.9%
RXORXO
Open-market buy02/1202/17532,276 sh$12.00$6,387,312+1.9%
RXORXO
Open-market buy25/11/2025/11/248,317 sh$10.61$88,243.37+3.1%
Director
RXORXO
Open-market buyAmendment25/11/1725/11/1918,700 sh2 trades$10.75avg.$201,025+25.8%
Jason S. KerrChief Accounting Officer
RXORXO
Open-market sale25/11/1025/11/1233,343 sh$11.57$385,778.51−43.4%
RXORXO
Open-market buy25/11/0725/11/1220,308 sh$12.37$251,209.96+125.4%
CEO
RXORXO
Open-market buy25/11/1025/11/1011,625 sh2 trades$12.85avg.$149,422No record
RXORXO
Open-market buy25/05/1425/05/167,500 sh$16.65$124,875+86.2%
RXORXO
Open-market buy25/05/0925/05/138,700 sh$14.41$125,367No record
RXORXO
Open-market buy24/11/1224/11/141,800 sh$27.89$50,202+13.4%
RXORXO
Open-market buy24/08/1224/08/1410,266,810 sh$20.21$207,492,230.1+59.3%
RXORXO
Open-market buy24/08/1224/08/1410,266,810 sh$20.21$207,492,230.1+59.3%
RXORXO
Open-market buy24/08/1224/08/1410,266,810 sh$20.21$207,492,230.1+59.3%
RXORXO
Open-market buy24/08/1224/08/1410,266,810 sh$20.21$207,492,230.1+59.3%
RXORXO
Open-market buy24/08/1224/08/1410,266,810 sh$20.21$207,492,230.1+59.3%
RXORXO
Open-market buy24/08/1224/08/1410,266,810 sh$20.21$207,492,230.1+59.3%